DCM Shriram Fine Chemicals posts Q1FY27 profit of ₹2.4 crore; appoints new MD
DCM Shriram Fine Chemicals posted a standalone net profit of ₹2.42 crore in Q1FY27, recovering from a Q4FY26 loss of ₹4.08 crore. Consolidated profits reached ₹2.59 crore. The quarter saw stable sequential revenue but lower year-on-year sales. Key governance updates include the resignation of MD Akshay Dhar and the appointment of Rudra Shriram as the new Managing Director.

*this image is generated using AI for illustrative purposes only.
DCM Shriram Fine Chemicals Limited returned to profitability in the first quarter of FY27, reporting a standalone net profit of ₹2.42 crore for the period ended June 30, 2026. This marks a significant turnaround from the net loss of ₹4.08 crore recorded in the immediately preceding quarter (Q4FY26). On a consolidated basis, the company reported a net profit of ₹2.59 crore, compared to a consolidated loss of ₹3.83 crore in Q4FY26.
Revenue from operations showed a slight contraction year-on-year but stabilized sequentially. Standalone net sales for Q1FY27 were ₹9,018.36 lakh, down from ₹9,792.28 lakh in the same quarter last year (Q1FY26). However, this represented an improvement from the ₹9,248.40 lakh logged in Q4FY26. Total revenue from operations, including other operating income, stood at ₹9,078.10 lakh on a standalone basis.
Leadership Changes
In a significant governance development, the Board of Directors approved several key personnel changes during its meeting on August 14, 2026:
- Resignation: Mr. Akshay Dhar resigned from his positions as Managing Director and CEO effective close of business hours on August 14, 2026. The company stated he is stepping away from day-to-day management to focus on leading new projects and expansion initiatives.
- New Appointment: Mr. Rudra Shriram, son of Chairman Alok B Shriram, was inducted as an Additional Director and appointed Managing Director for a five-year term effective August 15, 2026. He currently serves as Deputy Managing Director at DCM Shriram International Limited.
- Independent Director: Mr. Rakesh Malhotra was appointed as an Additional Director in the category of Non-Executive Independent Director for a five-year term, subject to member approval.
What the Numbers Show
The return to profitability was driven by a combination of reduced expenses and higher other income, despite a slight dip in core sales. Standalone other income rose to ₹81.86 lakh in Q1FY27 from ₹43.18 lakh in Q4FY26, contributing significantly to the bottom line given the thin operating margins.
Operating expenses remained relatively stable, with total expenses at ₹8,806.91 lakh in Q1FY27 compared to ₹9,833.47 lakh in Q4FY26. Notably, cost of materials consumed increased to ₹6,067.65 lakh from ₹5,693.39 lakh in the previous quarter, while employee benefits expense remained flat at ₹1,221.19 lakh. The reduction in overall expenses, coupled with the rise in other income, allowed the company to bridge the gap between revenue and costs, resulting in a pre-tax profit of ₹3.53 lakh versus a pre-tax loss of ₹4.82 lakh in Q4FY26.
| Metric | Q1FY27 (Standalone) | Q4FY26 (Standalone) | Q1FY26 (Standalone) |
|---|---|---|---|
| Revenue from Operations | ₹9,078.10 lakh | ₹9,308.11 lakh | ₹9,861.87 lakh |
| Other Income | ₹81.86 lakh | ₹43.18 lakh | ₹66.80 lakh |
| Total Expenses | ₹8,806.91 lakh | ₹9,833.47 lakh | ₹9,374.39 lakh |
| Profit Before Tax | ₹3.53 lakh | -₹4.82 lakh | ₹5.54 lakh |
| Net Profit | ₹2.42 lakh | -₹4.08 lakh | ₹4.13 lakh |
The financial results were reviewed by Kirtane & Pandit LLP, the statutory auditors, who issued an unmodified conclusion. The results have been prepared in accordance with Ind AS 34 and Regulation 33 of the SEBI LODR Regulations.
Historical Stock Returns for DCM Shriram Fine Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.44% | -1.37% | +7.72% | -46.84% | -46.84% | -46.84% |
How will the leadership transition to Rudra Shriram impact DCM Shriram Fine Chemicals' strategic direction and operational efficiency in the fine chemicals sector?
Given that profitability was driven largely by 'other income' rather than core operating margins, what specific measures are being taken to improve the sustainability of operating profits?
What is the outlook for raw material costs and input pricing volatility in the upcoming quarters, and how might this affect the company's cost structure?

































